General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Acelyrin ×
Acelyrin is a late-stage clinical biotech company focused on acquiring and accelerating the development of immunology medicines.